Vaccinated Blood Cancer Patients Still at Risk for Severe COVID-19 – MedPage Today

Patients with hematologic malignancies who had breakthrough COVID-19 infections still had high risk for severe or critical disease, according to a registry-based study.
Out of 113 reported cases of SARS-CoV-2 infection post-vaccination in people with blood…

Click here to view the original article.